Cargando…
Background to new treatments for COVID‐19, including its chronicity, through altering elements of the cytokine storm
Anti‐tumour necrosis factor (TNF) biologicals, Dexamethasone and rIL‐7 are of considerable interest in treating COVID‐19 patients who are in danger of, or have become, seriously ill. Yet reducing sepsis mortality by lowering circulating levels of TNF lost favour when positive endpoints in earlier si...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883210/ https://www.ncbi.nlm.nih.gov/pubmed/33580566 http://dx.doi.org/10.1002/rmv.2210 |